Dublin, Sept. 25, 2017 -- The "5G Monetisation: Will Gigabit LTE and 5G bring Higher Revenues?" report has been added to Research and Markets' offering.
This study on the monetisation of 4G and 5G first examines how 4G is currently monetised by MNOs given that this is a key challenge for the industry as a whole.
It then explores in depth the paths to monetising 5G and how to avoid the traps and pitfalls encountered with 4G.
The study gives views on the new business models and value chains that are likely to be created by 5G.
Finally, it analyses three scenarios for 5G monetisation.
Key Topics Covered:
1. Executive Summary
1.1. LTE monetisation
1.2. How could 5G get rid of LTE models?
1.3. Market forecasts
2. Methodology and definitions
2.1. General methodology of reports
2.2. Market assessment and forecasts
3. LTE monetisation
3.1. How is LTE currently monetised?
3.2. LTE is still difficult to monetise in Europe
3.3. Has LTE investment been profitable?
4. Will 5G kill LTE business models?
4.1. 5G has more specificities than former mobile technologies
4.2. A host of 5G technical trials are validating 5G capabilities
4.3. 5G brings in new opportunities
4.4. Three scenarios for 5G monetisation
5. Market forecasts
5.1. LTE market forecasts
5.2. 5G market forecasts
6. Annex: operator benchmark
7. Glossary
Leading MNOs, including:
- AT&T
- BT
- China Mobile
- Deutsche Telekom
- Etisalat
- KT
- Mobil1
- NTT DOCOMO
- Orange
- Proximus
- SK Telecom
- StarHub
- Telecom Italia
- TeliaSonera
- Telstra
- Verizon
Leading equipment vendors and chipset manufacturers, including:
- Ericsson
- Huawei
- Nokia
- Qualcomm
- Samsung
For more information about this report visit https://www.researchandmarkets.com/research/5hdj8z/5g_monetisation
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: 4G and 5G


Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Washington Post Publisher Will Lewis Steps Down After Layoffs
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 



